# Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

> **NCT07177352** · PHASE3 · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 13000 (estimated)

## Conditions studied

- Alzheimers Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT07177352
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-02
- **Primary completion:** 2035-07-31
- **Final completion:** 2035-07-31
- **Target enrollment:** 13000 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177352, "Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07177352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*